A team of US researchers has found that for people with HIV, current risk models underestimated cardiovascular events in both women and black men in high-income countries.
Cardiovascular disease is the leading cause of morbidity and mortality globally, posing a particularly significant threat to people with HIV (PWH), according to new study published in the journal Lancet HIV.
Previous studies have called into question whether these commonly used prediction models perform well among people with HIV, and there remains a gap in understanding of what these scores mean for PWH in low- and middle-income countries (LMICs).
Researchers from Massachusetts General Hospital, a founding member of the Mass General Brigham healthcare system, in collaboration with an international team of investigators, conducted a study to evaluate how well existing atherosclerotic cardiovascular disease (ASCVD) risk estimates could be used to predict cardiovascular outcomes in global populations with HIV.